Angiotensin receptor blockers (ARBs) and angiotensin converting enzyme inhibitors (ACEIs) are the two main drug classes used to suppress the deleterious effects of angiotensin in heart failure patients in general and in DMD patients specifically. Here, ACE is linked to Duchenne muscular dystrophy.